Clinical Trial Update: Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on ACY-241 given alone or in combination with pomalidomide and dexamethasone in multiple myeloma; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ACY-241
• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 1 | Status: TERMINATED